Logotipo do repositório

Randomized Clinical Trial for Clinical Response Evaluation in Crohn's Disease: Infliximab Versus Adalimumab

dc.contributor.authorBaima, Julio
dc.contributor.authorLima, Talles
dc.contributor.authorMoreira, Alecssandro
dc.contributor.authorBarros, Jaqueline de
dc.contributor.authorDorna, Mariana
dc.contributor.authorSilva, Rosemary da
dc.contributor.authorSibia, Carina
dc.contributor.authorRenosto, Fernanda
dc.contributor.authorFarinelli, Elen
dc.contributor.authorSaad-Hossne, Rogerio [UNESP]
dc.contributor.authorSassaki, Ligia [UNESP]
dc.contributor.institutionFac Med Botucatu
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-11-28T03:51:17Z
dc.date.available2018-11-28T03:51:17Z
dc.date.issued2016-03-01
dc.description.affiliationFac Med Botucatu, Botucatu, SP, Brazil
dc.description.affiliationUnesp Botucatu, Dept Digest Surg, Botucatu, SP, Brazil
dc.description.affiliationUnesp FMB, Botucatu, SP, Brazil
dc.description.affiliationUnespUnesp Botucatu, Dept Digest Surg, Botucatu, SP, Brazil
dc.description.affiliationUnespUnesp FMB, Botucatu, SP, Brazil
dc.format.extentS30-S30
dc.identifierhttp://dx.doi.org/10.1097/01.MIB.0000480181.61935.67
dc.identifier.citationInflammatory Bowel Diseases. Philadelphia: Lippincott Williams & Wilkins, v. 22, p. S30-S30, 2016.
dc.identifier.dimensionspub.1027602604
dc.identifier.doi10.1097/01.MIB.0000480181.61935.67
dc.identifier.issn1078-0998
dc.identifier.issn1536-4844
dc.identifier.orcid0000-0002-2540-4920
dc.identifier.orcid0000-0002-7319-8906
dc.identifier.orcid0000-0003-1451-8794
dc.identifier.orcid0000-0002-8166-0304
dc.identifier.orcid0000-0002-4035-3113
dc.identifier.orcid0000-0001-6523-7541
dc.identifier.urihttp://hdl.handle.net/11449/165476
dc.identifier.wosWOS:000393896400092
dc.language.isoeng
dc.publisherLippincott Williams & Wilkins
dc.publisherOxford University Press (OUP)
dc.relation.ispartofInflammatory Bowel Diseases
dc.relation.ispartofsjr2,511
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.sourceDimensions
dc.titleRandomized Clinical Trial for Clinical Response Evaluation in Crohn's Disease: Infliximab Versus Adalimumaben
dc.typeResumopt
dcterms.rightsHolderLippincott Williams & Wilkins
dspace.entity.typePublication
relation.isDepartmentOfPublication6e0a9036-4bd6-43e5-9556-6c2945320ec1
relation.isDepartmentOfPublication.latestForDiscovery6e0a9036-4bd6-43e5-9556-6c2945320ec1
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentCirurgia e Ortopedia - FMBpt

Arquivos